Literature DB >> 3304461

Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

P Aucouturier, A Barra, L Intrator, C Cordonnier, D Schulz, F Duarte, J P Vernant, J L Preud'homme.   

Abstract

Serum IgG subclasses were measured by a competitive indirect immunoassay with monoclonal antibodies in 31 leukemic patients before and after bone marrow transplantation. Antibodies to Hemophilus influenzae type b (Hib) capsular polysaccharide were determined in 28 cases. Abnormally low or borderline subclass (mostly IgG2 and IgG4) levels were found late after transplant in 23 infected and noninfected patients. These levels persisted for as long as 25 months, in association with low or borderline IgA levels in 78% of the cases. IgG2, IgG4, and IgA often showed a parallel evolution, whereas IgG1, IgG3, and IgM often varied together in the opposite way. Class but not subclass deficiencies were more frequent in patients with graft-v-host disease (GVHD). Subclass abnormalities predominated in infected patients, with mean levels correlating with the severity of infections; however, the abnormalities are not clearly predictive of infections in individual cases. Most patients with Hib pneumonia showed virtually no IgG antibody response to Hib, and one-half of the patients had a moderate IgM and IgA response. In the whole series, many sera collected greater than 1 year after graft contained very low or undetectable antibodies. Correlation between anti-Hib antibody and IgG2 levels was significant but weak because of discrepancies that were only partially explained by the subclass distribution of the antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304461

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

Authors:  I Quinti; A Velardi; S Le Moli; E Guerra; R D'Amelio; P Mastrantonio; M F Martelli; F Aiuti
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

Review 2.  Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Authors:  Paul Balmer; Andrew J Cant; Ray Borrow
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

Review 3.  Intravenous immunoglobulin for secondary immunodeficiency.

Authors:  P L Yap
Journal:  Blut       Date:  1990-01

Review 4.  Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.

Authors: 
Journal:  BMJ       Date:  1996-02-17

Review 5.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

6.  Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.

Authors:  B L Ferry; S A Misbah; P Stephens; Z Sherrell; H Lythgoe; E Bateman; C Banner; J Jones; N Groome; H M Chapel
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls.

Authors:  M A Avanzini; A M Carrà; R Maccario; M Zecca; G Zecca; A Pession; P Comoli; M Bozzola; A Prete; R Esposito; F Bonetti; F Locatelli
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

8.  Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.

Authors:  V Hammarström; K Pauksen; J Azinge; G Oberg; P Ljungman
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

9.  Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation.

Authors:  M A Avanzini; A M Carra; R Maccario; M Zecca; P Pignatti; M Marconi; P Comoli; F Bonetti; P De Stefano; F Locatelli
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

10.  Iatrogenic IgG2 deficiency in a leukaemic child. A case report.

Authors:  A W de Boer; G A de Vaan; C M Weemaes; J A Bakkeren
Journal:  Eur J Pediatr       Date:  1992-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.